Trial Profile
Stress and Inflammation in the Pathophysiology of Late Life Depression
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2023
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary) ; Celecoxib
- Indications Depression
- Focus Therapeutic Use
- 06 Mar 2023 Status changed from active, no longer recruiting to completed.
- 27 Jan 2022 Planned End Date changed from 30 Dec 2022 to 31 Dec 2022.
- 27 Jan 2022 Planned primary completion date changed from 31 Dec 2021 to 31 Dec 2022.